"10.1371_journal.pone.0044994","plos one","2012-09-14T00:00:00Z","Clémence Palazzo; Jean-François Ravaud; Ludovic Trinquart; Marie Dalichampt; Philippe Ravaud; Serge Poiraudeau","U738, INSERM, Paris, France; Centre dÉpidémiologie Clinique, Hôpital Hôtel Dieu AP-HP, Paris, France; Université Paris Descartes, PRES, Paris, France; Service de rééducation et réadaptation de lappareil locomoteur et des pathologies du rachis, Hôpital Cochin AP-HP, Paris, France; Institut fédératif de recherche sur le handicap, INSERM, Paris, France; U988, INSERM, Villejuif, France; UMR 8211, CNRS, Villejuif, France","Conceived and designed the experiments: CP JFR PR SP. Performed the experiments: CP JFR PR SP. Analyzed the data: CP LT MD. Contributed reagents/materials/analysis tools: CP LT MD SP PR. Wrote the paper: CP.","The authors have read the journals policy and have the following conflict: S. Poiraudeau received fees from Pfizer for consultancy. This does not alter the authors adherence to all the PLoS ONE policies on sharing data and materials. The other authors have declared that no competing interests exist. There is no patent, product in development or marketed product,… etc., associated with Pfizer.","2012","09","Clémence Palazzo","CP",6,FALSE,4,4,3,1,TRUE,TRUE,FALSE,0,NA,FALSE
